INCIDENCE AND RISK FACTORS FOR LOW LEVEL VIREMIA IN CHRONIC HEPATITIS B PATIENTS RECEIVING ANTIVIRAL TREATMENT

被引:0
|
作者
Hasanoglu, Imran [1 ]
Guner, Hatice Rahmet [2 ]
Zerdali, Esra Yerlikaya [3 ]
Tosun, Selma [4 ]
Onlen, Yusuf [5 ]
Yildirim, Figen [6 ]
Turunc, Tuba [7 ]
Gunal, Ozgur [8 ]
Batirel, Ayse [9 ]
Kaya, Selcuk [10 ]
Ozkaya, Deniz [11 ]
Altunal, Nilsun [12 ]
Tabak, Fehmi [13 ]
机构
[1] Ankara Yildirim Beyazit Univ, Ankara Bilkent City Hosp, Ankara, Turkiye
[2] Ankara City Hosp, Ankara, Turkiye
[3] Istanbul Haseki Training & Res Hosp, Istanbul, Turkiye
[4] Bozyaka Training & Res Hosp, Izmir, Turkiye
[5] Mustafa Kemal Univ, Fac Med, Antakya, Turkiye
[6] Antalya Training & Res Hosp, Antalya, Turkiye
[7] Adana City Hosp, Adana, Turkiye
[8] Samsun Training & Res Hosp, Samsun, Turkiye
[9] Kartal Lutfu Kirdal City Hosp, Istanbul, Turkiye
[10] Karadeniz Tech Univ, Fac Med, Trabzon, Turkiye
[11] Bakircay Univ, Cigli Training & Res Hosp, Izmir, Turkiye
[12] Umraniye Training & Res Hosp, Istanbul, Turkiye
[13] Cerrahpasa Univ, Cerrahpasa Med Fac, Istanbul, Turkiye
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1424-C
引用
收藏
页码:S527 / S527
页数:1
相关论文
共 50 条
  • [1] Risk factors of low-level viremia in chronic hepatitis B patients receiving Entecavir monotherapy: a retrospective cohort study
    Chen, He
    Fu, Juan-Juan
    Li, Li
    Wang, Xia
    Pan, Xiu-Cheng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (01) : 180 - 184
  • [2] LOW-LEVEL VIREMIA IN CHRONIC HEPATITIS B PATIENTS RECEIVING TENOFOVIR OR ENTECAVIR
    Adilijiang, Munire
    Zhang, Yongping
    HEPATOLOGY, 2022, 76 : S243 - S244
  • [3] Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment
    Li, Zhong-Bin
    Chen, Dan-Dan
    Jia, Yun-Fei
    He, Qing-Juan
    Cui, Li
    Du, Feng-Xia
    Kang, Yao-Jie
    Feng, Xin
    He, Mengwen
    Jin, Xue-Yuan
    Chen, Jing
    Wang, Yudong
    Ji, Dong
    Lau, George
    Wu, Shu-Gao
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [4] Low-Level Viremia in Hepatitis B Patients on Antiviral Treatment: Can We Ignore It?
    Min, Albert D.
    HEPATOLOGY, 2017, 66 (02) : 312 - 314
  • [5] Low-level viremia in patients with chronic hepatitis B receiving entecavir, tenofovir and tenofovir alafenamide
    Wang, Xiaohao
    Cai, Dachuan
    Juan, Zhang
    JOURNAL OF HEPATOLOGY, 2022, 77 : S878 - S878
  • [6] Risk Factors and Nomogram Model for Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients with Low-Level Viremia
    Chen, Yu-Ching
    Yang, Chun-Chi
    Kuo, Hsing-Tao
    Sheu, Ming-Jen
    Feng, I-Che
    Liu, Chung-Feng
    Sun, Chi-Shu
    Wang, Su-Hung
    Lin, Cheng-Yi
    Chen, Chi-Hsing
    Lin, Sheng-Hsiang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (09): : 1661 - 1671
  • [7] INCIDENCE AND RISK FACTORS FOR HEPATITIS IN PATIENTS RECEIVING ANTITUBERCULAR TREATMENT
    Singh, Manish Kumar
    Mamatha, S.
    Jain, Rashee
    Jha, Amit Kumar
    Nigam, Sanjay Kumar
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (01): : 1 - 7
  • [8] Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents
    Shin, Jung-ho
    Kwon, Hee Jin
    Jang, Hye Ryoun
    Lee, Jung Eun
    Gwak, Geum-Youn
    Huh, Wooseong
    Jung, Sin-Ho
    Lee, Joon Hyeok
    Kim, Yoon-Goo
    Kim, Dae Joong
    Oh, Ha Young
    MEDICINE, 2016, 95 (01)
  • [9] High serum leptin is an independent risk factor for nonresponse patients with low viremia to antiviral treatment in chronic hepatitis C
    YuichiroEguchi
    ToshihikoMizuta
    TsutomuYasutake
    AkitakaHisatomi
    RyuichiIwakiri
    IwataOzaki
    KazumaFujimoto
    World Journal of Gastroenterology, 2006, (04) : 556 - 560
  • [10] Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy
    Tamori, A.
    Abiru, S.
    Enomoto, H.
    Kioka, K.
    Korenaga, M.
    Tani, J.
    Enomoto, M.
    Sugiyama, M.
    Masaki, T.
    Kawada, N.
    Yatsuhashi, H.
    Nishiguchi, S.
    Mizokami, M.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 608 - 611